Avandia

Showing 10 posts of 25 posts found.

GSK’s Arixtra set for expanded licence

July 26, 2010
Sales and Marketing Arixtra, Avandia, GlaxoSmithKline, rotarix

GlaxoSmithKline is set to receive a green light to use its anti-clotting drug Arixtra to prevent spontaneous superficial-vein thrombosis (SVT). …

GSK takes £1.58bn hit from legal disputes

July 16, 2010
Sales and Marketing Avandia, GlaxoSmithKline, Paxcil, Seroxat

GlaxoSmithKline is set to pay £1.58 billion to settle three long-standing legal disputes, including litigation costs for its troubled diabetes …

Avandia

GSK accused of Avandia cover-up

July 14, 2010
Sales and Marketing Avandia, GlaxoSmithKline, diabetes

The ongoing battle over GlaxoSmithKline’s diabetes drug Avandia has taken another turn with US senators accusing the company of a …

Avastin packshot

Avandia to face European safety review

July 12, 2010
Sales and Marketing Avandia, GlaxoSmithKline, diabetes

GlaxoSmithKline’s type II diabetes drug Avandia, the subject of safety concerns since its launch in 2000, is to be reviewed …

Avandia

Avandia probe deepens

June 29, 2010
Sales and Marketing Avandia, GlaxoSmithKline, diabetes

GlaxoSmithKline has come under further scrutiny from the FDA after two new studies showed patients taking its troubled diabetes medication …

GSK hits back at Avandia safety probe

February 25, 2010
Sales and Marketing Avandia, diabetes

GlaxoSmithKline has hit back at allegations from US Senators that its diabetes drug Avandia raises the risk of heart attacks, …

Avandia

Reports raise fresh Avandia safety questions

February 23, 2010
Research and Development, Sales and Marketing Avandia, GlaxoSmithKline, diabetes

GlaxoSmithKline’s troubled diabetes drug Avandia has been hit by fresh reports from the US that it increases the risk of …

Avandia suffering less in Europe

December 10, 2007
Sales and Marketing Avandia, diabetes

New research by market data company TNS Healthcare suggests that fewer patients are being taken off Avandia in Europe than …

Dwindling sales mean job cuts at GSK

October 25, 2007
Sales and Marketing Avandia, diabetes

GlaxoSmithKline saw sales in its pharmaceutical division dip 2% in the third quarter, as falling demand for Avandia continued to …

Avandia scare casts doubt over its future for Alzheimer’s

June 13, 2007
Sales and Marketing Avandia, diabetes, safety

 New safety warnings about cardiovascular side-effects seen in patients taking Avandia have cast a shadow over the drug’s future as …

The Gateway to Local Adoption Series

Latest content